(HealthDay)—Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in patients with mild-to-moderate COVID-19, according to a study published online Jan. 21 in the…
Read More
COVID-19 plus measles? Kids aren’t getting their vaccines, and doctors are worried
COVID-19 has infected some of Dr. Sonder Crane’s youngest patients—the newborn who tested positive because its mother had the coronavirus, the 14-month old who caught it at day care. Now, on top of that, she and other pediatricians across the…
Read More
Investigational breast cancer vaccine plus immune therapy work well in tandem
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical…
Read More